Industry reports
Editor highlights

Search inside this page

Free Market Research Guides to Download

Pharmaceutical Analysis & Statistics in Oceania Countries, May 2013 (p5)

You might be interested in: therapeutics, cancer, drug, more »

» Purchase Premium Reports

121-170 of about 500 reports
Online Pharmaceutical Sales in Australia - Industry Market Research Report

Online Pharmaceutical Sales in Australia - Industry Market Research Report

  • $ 890
  • Industry report
  • August 2013
  • by Ibisworld

Stable condition: Strong competition and regulatory hurdles constrain industry growth Online Pharmaceutical Sales in Australia Companies in this industry primarily sell pharmaceutical products via the ...

  • Industries : Pharmaceutical
  • Countries : Australia
Online Vitamin and Supplement Sales in Australia - Industry Market Research Report

Online Vitamin and Supplement Sales in Australia - Industry Market Research Report

  • $ 890
  • Industry report
  • August 2013
  • by Ibisworld

Growth in supplements: The industry will continue to benefit from the expanding online retail market Online Vitamin and Supplement Sales in Australia This industry includes specialist online retailers ...

  • Industries : Vitamin and Supplement
  • Countries : Australia
Squamous Non-Small Cell Lung Cancer - Pipeline Review, H2 2013

Squamous Non-Small Cell Lung Cancer - Pipeline Review, H2 2013

  • $ 2 000
  • Company report
  • July 2013
  • by Global Markets Direct

Squamous Non-Small Cell Lung Cancer - Pipeline Review, H2 2013 Summary Global Markets Direct's, 'Squamous Non-Small Cell Lung Cancer - Pipeline Review, H2 2013', provides an overview of the indication's ...

  • Industries : Pathology
  • Countries : World, United States, New Zealand, Australia
Nausea - Pipeline Review, H2 2013

Nausea - Pipeline Review, H2 2013

  • $ 2 000
  • Company report
  • July 2013
  • by Global Markets Direct

Nausea - Pipeline Review, H2 2013 Summary Global Markets Direct's, 'Nausea - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides information ...

  • Industries : Therapy
  • Countries : World, Australia, United States, Japan
Biovail Laboratories International SRL - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Biovail Laboratories International SRL - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2013
  • by Global Data

Summary Biovail Laboratories International SRL is engaged in developing, manufacturing, and selling pharmaceutical products and licenses its intellectual property.The company is headquatered in Barbados. ...

  • Industries : Drug Delivery Technology
  • Countries : Canada, Barbados, Australia, World, United States, North America
Dermatologicals in New Zealand

Dermatologicals in New Zealand

  • $ 898
  • Industry report
  • July 2013
  • by Euromonitor International

A Univesity of Otago study has found that hospital admissions from infectious diseases have increased significantly during the last 20 years, a trend which is out of sync with other developed countries. ...

  • Industries : Drug and Medication
  • Countries : New Zealand
Consumer Health in New Zealand

Consumer Health in New Zealand

  • $ 2 394
  • Industry report
  • July 2013
  • by Euromonitor International

Consumer health demonstrated positive growth during 2012, on the back of growing consumer awareness of disease prevention and burgeoning health and wellness trends within New Zealand. In fact, consume ...

  • Industries : Drug and Medication
  • Countries : New Zealand
Emergency Contraception Market Analysis in New Zealand

Emergency Contraception Market Analysis in New Zealand

  • $ 898
  • Industry report
  • July 2013
  • by Euromonitor International

Euromonitor International's report offers a comprehensive guide to the size and shape of the industry at a national level. It provides the latest retail sales data from 2006 to 2010 , allowing you to ...

  • Industries : Drug and Medication
  • Countries : New Zealand
Calming and Sleeping Market Analysis in New Zealand

Calming and Sleeping Market Analysis in New Zealand

  • $ 898
  • Industry report
  • July 2013
  • by Euromonitor International

Calming and sleeping products represented one of the most dynamic consumer health categories in 2010, demonstrating that the amount of people who are aware of the importance of adequate rest and a good ...

  • Industries : Vitamin and Supplement
  • Countries : New Zealand
Digestive Remedies Market Analysis in New Zealand

Digestive Remedies Market Analysis in New Zealand

  • $ 898
  • Industry report
  • July 2013
  • by Euromonitor International

Towards the latter end of the review period, consumers were extremely price conscious and this trend continued within digestive remedies during 2011. Euromonitor International's report offers a comprehensive ...

  • Industries : Over-the-counter Drug
  • Countries : New Zealand
NRT Smoking Cessation Aids Market Analysis in New Zealand

NRT Smoking Cessation Aids Market Analysis in New Zealand

  • $ 898
  • Industry report
  • July 2013
  • by Euromonitor International

One of the biggest changes to tobacco excise taxation over the review period occurred during 2010, when the government implemented a range of excise tax increases levied on cigarettes, cigars, cigarillos ...

  • Industries : Drug and Medication
  • Countries : New Zealand
Vitamins and Dietary Supplements Market Analysis in New Zealand

Vitamins and Dietary Supplements Market Analysis in New Zealand

  • $ 898
  • Industry report
  • July 2013
  • by Euromonitor International

br> Euromonitor International's report offers a comprehensive guide to the size and shape of the industry at a national level. It provides the latest retail sales data from 2007 to 2011, allowing you to ...

  • Industries : Vitamin and Supplement
  • Countries : New Zealand
Ear Care Market Analysis in New Zealand

Ear Care Market Analysis in New Zealand

  • $ 898
  • Industry report
  • July 2013
  • by Euromonitor International

Ear care in New Zealand was stagnating in 2010, with no special or unique growth drivers. Euromonitor International's report offers a comprehensive guide to the size and shape of the industry at a national ...

  • Industries : Drug and Medication
  • Countries : New Zealand
Cough, Cold and Allergy (Hay Fever) Remedies Market Analysis in New Zealand

Cough, Cold and Allergy (Hay Fever) Remedies Market Analysis in New Zealand

  • $ 898
  • Industry report
  • July 2013
  • by Euromonitor International

This followed an agreement by the cabinet in September 2009 to reclassify these two drugs considering the fact they are active ingredients used in the manufacture of the Class A controlled drug methamphetamine. ...

  • Industries : Drug and Medication
  • Countries : New Zealand
Analgesics Market Analysis in New Zealand

Analgesics Market Analysis in New Zealand

  • $ 898
  • Industry report
  • July 2013
  • by Euromonitor International

Acetaminophen accounted for 39% of analgesics current retail value sales in 2011. In addition to falling sales within acetaminophen, aspirin has also reached a very high level of maturity. Euromonito ...

  • Industries : Drug and Medication
  • Countries : New Zealand
photonamic GmbH & Co. KG - Pharmaceuticals & Healthcare - Deals and Alliances Profile

photonamic GmbH & Co. KG - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2013
  • by Global Data

Summary photonamic GmbH and Co. KG (Photonamic) is a medical device company. The company develops 5-aminolevulinic acid in the field of fluorescence diagnosis and photodynamic therapy. Its product is Gliolan, ...

  • Industries : Pharmaceutical
  • Countries : Australia, World
Alchemia Limited (ACL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Alchemia Limited (ACL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2013
  • by Global Data

Summary Alchemia Limited (Alchemia) is a biotechnology company. It discovers and develops human therapeutic products based on its extensive expertise in chemistry. The company focuses on the development ...

  • Industries : Pharmaceutical
  • Countries : Australia
Merger & Acquisition in Pharmaceuticals & Healthcare Industry: Acuvax Ltd (ACU)

Merger & Acquisition in Pharmaceuticals & Healthcare Industry: Acuvax Ltd (ACU)

  • $ 250
  • Company report
  • July 2013
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Drug and Medication
  • Countries : Australia, United States
Australian Pharmaceutical Industries Ltd in Retailing (Australia)

Australian Pharmaceutical Industries Ltd in Retailing (Australia)

  • $ 153
  • Company report
  • July 2013
  • by Euromonitor International

Australian Pharmaceutical Industries Ltd is planning for rapid expansion in Australia, with the aim of opening at least 400 Priceline stores by 2014. This target amounts to an expansion of up to 50% from ...

  • Industries : Pharmaceutical
  • Countries : Australia
Zuellig Australia Pharmacy Services Pty Ltd in Retailing (Australia)

Zuellig Australia Pharmacy Services Pty Ltd in Retailing (Australia)

  • $ 153
  • Company report
  • July 2013
  • by Euromonitor International

Zuellig Australia Pharmacy Services Pty Ltd is committed to investing in its core business of healthcare in order to help this business grow through organic business expansion. The company is also prepared ...

  • Industries : Pharmacies and Drug Stores, E-commerce
  • Countries : Australia
Vascular Closure Systems, Inc. - Product Pipeline Analysis, 2013 Update

Vascular Closure Systems, Inc. - Product Pipeline Analysis, 2013 Update

  • $ 750
  • Company report
  • July 2013
  • by Global Data

Summary Vascular Closure Systems, Inc (VCS) is a medical device company. The company develops and commercializes vascular access closure technology for the interventional cardiology market. It develops ...

  • Industries : Drug Discovery and Development
  • Countries : United States, Philippines, New Zealand, Australia, Singapore
Vitamin and Supplement Stores in Australia - Industry Market Research Report

Vitamin and Supplement Stores in Australia - Industry Market Research Report

  • $ 890
  • Industry report
  • July 2013
  • by Ibisworld

Healthy growth: Increasing health consciousness and sports participation will enhance industry performance Vitamin and Supplement Stores in Australia This industry consists of physical stores that mainly ...

  • Industries : Vitamin and Supplement
  • Countries : Australia
iNova Pharmaceuticals (Symbol:Australia) SWOT Analysis, Strategy, Revenues and Profits

iNova Pharmaceuticals (Symbol:Australia) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • July 2013
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pharmaceutical
  • Countries : Australia
Taisho Pharmaceutical Co., Ltd. (Symbol:4535) SWOT Analysis, Strategy, Revenues and Profits

Taisho Pharmaceutical Co., Ltd. (Symbol:4535) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • July 2013
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pharmaceutical
  • Countries : Japan, Philippines, United States, Asia, Australia, Indonesia
Basal Cell Carcinoma (Basal Cell Epithelioma) - Pipeline Review, H1 2013

Basal Cell Carcinoma (Basal Cell Epithelioma) - Pipeline Review, H1 2013

  • $ 2 000
  • Company report
  • June 2013
  • by Global Markets Direct

Basal Cell Carcinoma (Basal Cell Epithelioma) - Pipeline Review, H1 2013 Summary Global Markets Direct's, 'Basal Cell Carcinoma (Basal Cell Epithelioma) - Pipeline Review, H1 2013', provides an overview ...

  • Industries : Pathology
  • Countries : World, Australia
Australian Pharmaceutical Industries Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Australian Pharmaceutical Industries Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • June 2013
  • by MarketLine

Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Pharmaceutical
  • Countries : Australia
New Zealand Pharmaceuticals Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

New Zealand Pharmaceuticals Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • June 2013
  • by MarketLine

Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Pharmaceutical
  • Countries : New Zealand
Brodalumab (Psoriasis) - Forecast and Market Analysis to 2022

Brodalumab (Psoriasis) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • May 2013
  • by Global Data

Brodalumab (Psoriasis) - Forecast and Market Analysis to 2022 Summary Psoriasis is an incurable genetic, systemic, inflammatory, and chronic skin disorder with an overall prevalence of 2-3% worldwide ...

  • Industries : Pathology
  • Countries : World, Brazil, Spain, Italy, France, Germany, Japan, Australia, Europe, United States, United Kingdom, China
Pegasys (Hepatitis C Virus) - Forecast and Market Analysis to 2022

Pegasys (Hepatitis C Virus) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • May 2013
  • by Global Data

Pegasys (Hepatitis C Virus) - Forecast and Market Analysis to 2022 Summary Hepatitis C is a liver infection caused by the hepatitis C virus (HCV) that results in acute or chronic presentation. The disease ...

  • Industries : Pathology
  • Countries : World, Brazil, Spain, Italy, France, Germany, Japan, United States, Australia, Europe, United Kingdom, China
Secukinumab (Psoriasis) - Forecast and Market Analysis to 2022

Secukinumab (Psoriasis) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • May 2013
  • by Global Data

Secukinumab (Psoriasis) - Forecast and Market Analysis to 2022 Summary Psoriasis is an incurable genetic, systemic, inflammatory, and chronic skin disorder with an overall prevalence of 2-3% worldwide ...

  • Industries : Pathology
  • Countries : World, Brazil, Spain, Italy, France, Germany, Japan, Australia, Europe, United States, United Kingdom, China

» Read our Company Profiles

13 Companies

GlaxoSmithKline P.L.C.

United States

Management Strategies

United States

Abbott Laboratories

United States

Johnson and Johnson

United States

Medtronic Inc.

United States

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.